Screening cardiovascular risk factors of diabetes patients in the primary diabetes clinics.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
30 Jul 2021
30 Jul 2021
Historique:
received:
29
12
2020
accepted:
04
07
2021
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
21
8
2021
Statut:
ppublish
Résumé
To evaluate the atherosclerotic cardiovascular diseases (ASCVD) risk factors in type 2 diabetes patients from the primary diabetes clinics for further comprehensive intervention in China.A cross-sectional study was conducted in 5 primary diabetes chain hospitals in Beijing, Lanzhou, Harbin, Chengdu, and Taiyuan in continuous patients with type 2 diabetes from March 2016 to December 2019. The data collected at the first visit were analyzed, and proportions of patients reached the targets (glycosylated hemoglobin [HbA1c] < 7%, blood pressure < 130/80 mm Hg, and low-density lipoprotein cholesterol [LDL-C] < 2.6mmol/l) were calculated. The clinical characteristics and the associated factors with achievement in HbA1c, blood pressure, and LDL-C targets were analyzed.A total of 20,412 participants, including 11,353 men (55.6%), with an average age of (59.4 ± 10.4) years were enrolled. Nearly 95% diabetes had one or more ASCVD risk factors other than hyperglycemia. The control rates of HbA1c, blood pressure, and LDL-C were 26.5%, 27.8%, and 42.6%, respectively. Only 4.1% patients achieved all 3 targets. Nearly 95% patients had one or more ASCVD risk factors other than hyperglyciemia. Diabetes duration, family history, and overweight/obesity were associated with the number of aggregated ASCVD risk factors. The patients with older age, no overweight/obesity, not smoking, less ASCVD risk factors, and having special diabetes care insurance (Chengdu) were associated with a higher control rates.To deal with poor control status, global management of ASCVD risk factors, weight loss, and smoking cessation must be emphasized in the primary diabetes care settings. Special diabetes care insurance should be advocated.Current ClinicalTrial.gov protocol ID NCT03707379. Date of Registration: October 16, 2018. https://clinicaltrials.gov.
Identifiants
pubmed: 34397707
doi: 10.1097/MD.0000000000026722
pii: 00005792-202107300-00028
pmc: PMC8322505
doi:
Banques de données
ClinicalTrials.gov
['NCT03707379']
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26722Subventions
Organisme : Beijing Tsinghua Changgung Hospital Fund
ID : 12016C6007
Informations de copyright
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Metabolism. 2003 Aug;52(8 Suppl 1):19-23
pubmed: 12939735
Circulation. 2013 Jan 1;127(1):e6-e245
pubmed: 23239837
Appl Nurs Res. 2016 Feb;29:202-5
pubmed: 26856514
J Diabetes Sci Technol. 2017 Jan;11(1):117-122
pubmed: 27246670
Endocr Pract. 2019 Jul;25(7):678-683
pubmed: 30865527
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Can J Cardiol. 2010 Jun-Jul;26(6):297-302
pubmed: 20548975
Diabetes Care. 2008 Jul;31(7):1389-91
pubmed: 18375411
Niger J Clin Pract. 2016 Nov-Dec;19(6):784-792
pubmed: 27811452
Prev Med. 2017 Mar;96:129-134
pubmed: 28007493
Am J Med. 2013 Oct;126(10):925.e11-22
pubmed: 23810406
N Engl J Med. 2015 Oct 29;373(18):1720-32
pubmed: 26510021
JAMA. 2017 Jun 27;317(24):2515-2523
pubmed: 28655017
Diabetes Care. 2018 Feb;41(2):293-302
pubmed: 29150530
Diabetol Metab Syndr. 2016 Jan 22;8:7
pubmed: 26807158
Lancet. 2003 Jun 14;361(9374):2005-16
pubmed: 12814710
J Diabetes Res. 2019 Jan 03;2019:6516581
pubmed: 30719455
BMC Med. 2014 Oct 23;12:188
pubmed: 25338506
Int J Obes (Lond). 2017 Nov;41(11):1621-1626
pubmed: 28736442
Diabetes Care. 2012 Apr;35(4):774-9
pubmed: 22344609
Diabetes Care. 2009 Nov;32 Suppl 2:S357-61
pubmed: 19875581
Cardiovasc Diabetol. 2016 Apr 05;15:61
pubmed: 27048217
Diab Vasc Dis Res. 2013 Nov;10(6):505-13
pubmed: 23975724
Am J Hum Genet. 1994 Sep;55(3):566-73
pubmed: 8079995
Zhonghua Liu Xing Bing Xue Za Zhi. 2002 Feb;23(1):24-7
pubmed: 12015104
N Engl J Med. 2010 Mar 25;362(12):1090-101
pubmed: 20335585
Int J Endocrinol. 2018 Apr 19;2018:8457538
pubmed: 29849624
J Diabetes Complications. 2013 Jan-Feb;27(1):34-40
pubmed: 23062328
Diabetes Ther. 2018 Apr;9(2):583-612
pubmed: 29417495
J Diabetes Complications. 2016 Mar;30(2):199-205
pubmed: 26718938
JAMA. 2013 Sep 4;310(9):948-59
pubmed: 24002281
Can J Diabetes. 2017 Jun;41(3):297-304
pubmed: 28318938
Diabetes Res Clin Pract. 2014 Dec;106 Suppl 2:S328-32
pubmed: 25550062
Diabetes Care. 2017 Dec;40(12):1763-1770
pubmed: 28986504
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Med Care. 2011 Jun;49(6):605-10
pubmed: 21422952
J Diabetes Res. 2019 Nov 15;2019:5631620
pubmed: 31828163